Close

Biogen (BIIB) PT Raised to $455 at Guggenheim

June 9, 2021 6:07 AM EDT
Get Alerts BIIB Hot Sheet
Price: $201.48 +4.30%

Rating Summary:
    29 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja raised the price target on Biogen (NASDAQ: BIIB) to $455.00 (from $325.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change